Related Experiment Videos
Clinical and pathologic factors predicting axillary lymph node involvement in breast cancer
M Noguchi1, M Kurosumi, H Iwata
1Operation Center, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa 920-8641, Japan.
Breast Cancer (Tokyo, Japan)
|October 13, 2000
Summary
Diagnosing axillary disease in breast cancer is challenging. Sentinel lymph node biopsy is useful for staging, but further research is needed to confirm its role over axillary lymph node dissection.
Area of Science:
- Oncology
- Surgical Pathology
- Medical Imaging
Background:
- Accurate staging of axillary lymph node involvement is crucial for breast cancer management.
- Current diagnostic methods for axillary disease present challenges and controversies.
Purpose of the Study:
- To evaluate various methods for assessing axillary lymph node status in breast cancer patients.
- To determine the utility of sentinel lymph node biopsy compared to other diagnostic techniques.
Main Methods:
- Clinical assessment using CT, PET, and US imaging.
- Histologic assessment for peritumoral lymphatic invasion.
- Biologic assessment via gelatinolytic activity and in situ zymography.
- Sentinel lymph node (SLN) biopsy.
Main Results:
- Clinical imaging and biologic assessments showed limitations in detecting axillary lymph node disease.
- Histologic assessment effectively identified false-negative cases from SLN biopsy.
- Sentinel lymph node biopsy demonstrated utility in assessing axillary nodal status.
Conclusions:
- Sentinel lymph node biopsy is a valuable tool for staging breast cancer axillary lymph nodes.
- Axillary lymph node dissection may be avoidable for patients with small tumors and negative SLN results.
- Further studies are required to establish SLN biopsy as a replacement for routine axillary lymph node dissection in operable breast cancer.